Skip to main content

Free Content Antidepressants and Pregnancy: Continued Evidence of Harm—Still No Evidence of Benefit

Download Article:
 Download
(PDF 191.583984375 kb)
 

Abstract:

Antidepressant medication use during pregnancy is increasing. It is essential that women of childbearing age, pregnant women, and their health care providers be aware of the risks, benefits, and alternatives prior to taking these agents. The best available evidence suggests that antidepressant use by pregnant women may be associated with miscarriage, birth defects, preterm birth, decreased birth weight, neonatal behavioral syndrome, persistent pulmonary hypertension in the newborn, neonatal electrocardiogram (EKG) changes, and behavioral effects. Evidence of benefit is lacking. The hope that improved maternal mood through medication would lead to better pregnancy results has not been realized; the antidepressant-exposed pregnancies are faring worse. The available evidence raises the question: Are we exposing a generation of women and their babies to drugs that are causing significantly more harm than good?

Keywords: ANTIDEPRESSANTS; DEPRESSION; PREGNANCY; SEROTONIN REUPTAKE INHIBITORS

Document Type: Research Article

DOI: https://doi.org/10.1891/1559-4343.13.3.190

Publication date: 2011-12-01

More about this publication?
  • Access Key
  • Free ContentFree content
  • Partial Free ContentPartial Free content
  • New ContentNew content
  • Open Access ContentOpen access content
  • Partial Open Access ContentPartial Open access content
  • Subscribed ContentSubscribed content
  • Partial Subscribed ContentPartial Subscribed content
  • Free Trial ContentFree trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more